313 related articles for article (PubMed ID: 23014188)
1. Venous thromboembolism in the hematologic malignancies.
Falanga A; Marchetti M; Russo L
Curr Opin Oncol; 2012 Nov; 24(6):702-10. PubMed ID: 23014188
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism in the hematologic malignancies.
Falanga A; Marchetti M
J Clin Oncol; 2009 Oct; 27(29):4848-57. PubMed ID: 19752334
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma.
Wun T; White RH
Thromb Res; 2010 Apr; 125 Suppl 2():S96-102. PubMed ID: 20434017
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis.
Zamagni E; Brioli A; Tacchetti P; Zannetti B; Pantani L; Cavo M
Semin Thromb Hemost; 2011 Apr; 37(3):209-19. PubMed ID: 21455855
[TBL] [Abstract][Full Text] [Related]
5. Prevention of deep vein thrombosis in cancer patients.
Lee AY
Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis.
Uaprasert N; Voorhees PM; Mackman N; Key NS
Eur J Cancer; 2010 Jul; 46(10):1790-9. PubMed ID: 20385482
[TBL] [Abstract][Full Text] [Related]
7. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
Palumbo A; Rajkumar SV; Dimopoulos MA; Richardson PG; San Miguel J; Barlogie B; Harousseau J; Zonder JA; Cavo M; Zangari M; Attal M; Belch A; Knop S; Joshua D; Sezer O; Ludwig H; Vesole D; Bladé J; Kyle R; Westin J; Weber D; Bringhen S; Niesvizky R; Waage A; von Lilienfeld-Toal M; Lonial S; Morgan GJ; Orlowski RZ; Shimizu K; Anderson KC; Boccadoro M; Durie BG; Sonneveld P; Hussein MA;
Leukemia; 2008 Feb; 22(2):414-23. PubMed ID: 18094721
[TBL] [Abstract][Full Text] [Related]
8. Management of thromboembolism in hematologic malignancies.
Chong BH; Lee SH
Semin Thromb Hemost; 2007 Jun; 33(4):435-48. PubMed ID: 17525901
[TBL] [Abstract][Full Text] [Related]
9. Thrombosis in Lymphoma Patients and in Myeloma Patients.
Yokoyama K
Keio J Med; 2015; 64(3):37-43. PubMed ID: 26212069
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism incidence in hematologic malignancies.
Kekre N; Connors JM
Blood Rev; 2019 Jan; 33():24-32. PubMed ID: 30262170
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy.
Musallam KM; Dahdaleh FS; Shamseddine AI; Taher AT
Thromb Res; 2009 Mar; 123(5):679-86. PubMed ID: 18992924
[TBL] [Abstract][Full Text] [Related]
12. Real-life practices for preventing venous thromboembolism in multiple myeloma patients: a cohort study from the French health insurance database.
Palmaro A; Rougé-Bugat ME; Gauthier M; Despas F; Moulis G; Lapeyre-Mestre M
Pharmacoepidemiol Drug Saf; 2017 May; 26(5):578-586. PubMed ID: 28198064
[TBL] [Abstract][Full Text] [Related]
13. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature.
Tufano A; Guida A; Di Minno MN; Prisco D; Cerbone AM; Di Minno G
Semin Thromb Hemost; 2011 Apr; 37(3):267-74. PubMed ID: 21455860
[TBL] [Abstract][Full Text] [Related]
14. [Thoughts about thromboembolic events prophylaxis in cancer patients].
Pikó B; Kremer IM; Rahoty P; Bassam A; Dimák S; Kis A; Csiffári M; Rus-Gal P; Szabó Z; Veréb B; Zsilak J
Magy Onkol; 2011 Sep; 55(3):164-9. PubMed ID: 21918741
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations.
Hussein MA
Thromb Haemost; 2006 Jun; 95(6):924-30. PubMed ID: 16732369
[TBL] [Abstract][Full Text] [Related]
16. Association between cancer types, cancer treatments, and venous thromboembolism in medical oncology patients.
Streiff MB
Clin Adv Hematol Oncol; 2013 Jun; 11(6):349-57. PubMed ID: 24472803
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
Streiff MB
J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
[TBL] [Abstract][Full Text] [Related]
18. Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.
Tran QN
Am J Hosp Palliat Care; 2010 Sep; 27(6):416-9. PubMed ID: 20197558
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated venous thrombosis in the surgical setting.
Behranwala KA; Williamson RC
Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism and risk stratification in hematological malignancies.
Sanfilippo KM
Thromb Res; 2022 May; 213 Suppl 1():S16-S21. PubMed ID: 36210555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
